Detalhe da pesquisa
1.
Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
HIV Med
; 16 Suppl 1: 14-23, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25711319
2.
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
HIV Med
; 16(5): 297-306, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25585664
3.
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe.
Infection
; 42(4): 757-62, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24902520
4.
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/µL in the post-combination antiretroviral therapy era.
Clin Infect Dis
; 57(7): 1038-47, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23921881
5.
Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections.
EBioMedicine
; 2(7): 699-705, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26288842
6.
The heart production in energy-depleted human erythrocytes induced by glucose, inosine and adenine.
Scand J Clin Lab Invest
; 37(1): 85-8, 1977 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28559
7.
The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro.
Inflamm Res
; 48(7): 369-79, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10450786